Trials / Not Yet Recruiting
Not Yet RecruitingNCT06958146
Azithromycin for Preventing Maternal and Neonatal Infections During Labor.
Impact of Single Dose Azithromycin During Labor on Maternal and Neonatal Infections
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Armed Forces Hospital, Pakistan · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
In this study, we want to see the role of the antibiotic, azithromycin, in preventing maternal and neonatal infections, if the drug is given intrapartum to the mother
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oral azithromycin | we will be administering single-dose oral azithromycin to ladies who go into labor and have no risk factors for sepsis, as there is increased risk of postpartum sepsis in both mother and neonate after normal vaginal delivery in low-income and middle-income countries |
| OTHER | no azithromycin | participants in this arm will be given only standard labor care and no oral azithromycin |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2025-08-31
- Completion
- 2025-08-31
- First posted
- 2025-05-06
- Last updated
- 2025-05-06
Source: ClinicalTrials.gov record NCT06958146. Inclusion in this directory is not an endorsement.